Cargando…
Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance
BACKGROUND: Taxanes such as paclitaxel and docetaxel are used successfully to treat breast cancer, usually in combination with other agents. They interfere with microtubules causing cell cycle arrest; however, the mechanisms underlying the clinical effects of taxanes are yet to be fully elucidated....
Autores principales: | Kenicer, Juliet, Spears, Melanie, Lyttle, Nicola, Taylor, Karen J, Liao, Linda, Cunningham, Carrie A, Lambros, Maryou, MacKay, Alan, Yao, Cindy, Reis-Filho, Jorge, Bartlett, John MS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203938/ https://www.ncbi.nlm.nih.gov/pubmed/25312014 http://dx.doi.org/10.1186/1471-2407-14-762 |
Ejemplares similares
-
Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells
por: Buckley, Amy M., et al.
Publicado: (2019) -
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells
por: Sprowl, Jason A, et al.
Publicado: (2012) -
A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial
por: Spears, Melanie, et al.
Publicado: (2016) -
Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020) -
Characterisation of a 4A QTL for Metribuzin Resistance in Wheat by Developing Near-Isogenic Lines
por: Bhattarai, Rudra, et al.
Publicado: (2021)